Gastroenteropancreatic endocrine tumors: prognostic factors
Bordi, C.
Pathologica 95(5): 248-250
2003
ISSN/ISBN: 0031-2983 PMID: 14988998 Document Number: 559671
Document emailed within 1 workday
Related Documents
Tartaglia, A.; Bianchini, S.; Vezzadini, P. 2003: Biochemical diagnosis of gastroenteropancreatic endocrine tumors Minerva Medica 94(1): 1-7Tomassetti, P.; Campana, D.; Nori, F.; Piscitelli, L.; Salomone, L.; Pezzilli, R.; Corinaldesi, R. 2006: Medical treatment of endocrine gastroenteropancreatic tumors Jop: Journal of the Pancreas 7(1): 145-149
Kisker, O.; Bartsch, D.; Weinel, R.J.; Joseph, K.; Welcke, U.H.; Zaraca, F.; Rothmund, M. 1997: The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors Journal of the American College of Surgeons 184(5): 487-492
Grassi, M.; Fraioli, A. 1988: Gastroenteropancreatic endocrine system and crenotherapy with mineral waters La Clinica Terapeutica 127(5): 379-384
Weber, M. 2014: New directions in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): shifting from symptom management to targeting tumors Clinical Advances in Hematology and Oncology: H&o 12(12 Suppl 19: 12-17
Syrigos, K.N.; Sitara, D.; Georgiou, E.; Harrington, K.J. 2002: Cytotoxic therapy of gastroenteropancreatic (GEP) tumors Anticancer Research 22(2b): 1311-1314
Magno, L.; Sivero, L.; Napolitano, V.; Ruggiero, S.; Fontanarosa, G.; Massa, S. 2010: The role of endoscopy in gastroenteropancreatic neuroendocrine tumors Il Giornale di Chirurgia 31(6-7): 341-343
Kos-Kudła, B. 2006: Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET) Endokrynologia Polska 57(3): 267-272
Gloeckner, K.; Rudolph, P.; Feller, A.C. 1998: Prognostic factors for gastrointestinal stromal tumors Verhandlungen der Deutschen Gesellschaft für Pathologie 82: 253-260
Lazáry, A.; Bors, I.án.B.él.; Szövérfi, Z.; Rónai, M.ár.; Varga, P.ét.P.ál. 2012: Prognostic factors of primary spinal tumors Ideggyogyaszati Szemle 65(5-6): 161-167
Darbà, J.; Ascanio, M. 2019: Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain Neuro Endocrinology Letters 39(8): 537-543
Wabersich, J.; Fracas, M.; Mazzer, S.; Marchetti, M.; Altavilla, G. 1998: The value of the prognostic factors in ovarian granulosa cell tumors European Journal of Gynaecological Oncology 19(1): 69-72
Hillemanns, M.; Päsold, S.; Böttcher, K.; Höfler, H. 1998: Prognostic factors of gastrointestinal stromal tumors of the stomach Verhandlungen der Deutschen Gesellschaft für Pathologie 82: 261-266
Páez Borda, A.; Martín Osés, E.; de la Cal López, M.; Llorente Abarca, C.; Berenguer Sánchez, A. 1997: Analysis of prognostic factors in superficial bladder tumors Archivos Espanoles de Urologia 50(2): 121-126
Stoter, G.; Bosl, G.J.; Droz, J.P.; Fossa, S.D.; Freedman, L.S.; Geller, N.L.; Horwich, A.; Jones, W.G.; Kaye, S.B.; Mead, G.M. 1990: Prognostic factors in metastatic germ cell tumors Progress in Clinical and Biological Research 357: 313-319
Salinas Sánchez, A.S.; Moreno Avilés, J.; Tomás Ros, M.; Martínez Pertusa, P.; Server Falgas, G. 1988: Prognostic factors in renal tumors of urothelial origin Archivos Espanoles de Urologia 41(5): 335-339
Muro-Cacho, C.A.; Cantor, A.B.; Morgan, M. 2000: Prognostic factors in malignant gastrointestinal stromal tumors Annals of Clinical and Laboratory Science 30(3): 239-247
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Boneschi, M.; Erba, M.; Cusmai, F.; Eusebio, D.; Miani, S.; Bortolani, E.M. 1999: Primary retroperitoneal tumors. Treatment modality and prognostic factors Minerva Chirurgica 54(11): 763-768
Komatsu, H.; Katayama, T.; Murakami, K.; Sagara, Y.; Hayashi, K. 1991: Surgical indication based on prognostic factors in pT1 tumors of the lung Kyobu Geka. Japanese Journal of Thoracic Surgery 44(1): 61-64